Toyota|$17.76 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.82 (¥4,271)-1.13%▼ (in JPY terms)
SoftBank|$20.60 (¥3,281)-3.95%▼ (in JPY terms)
MUFG|$20.64 (¥3,287)-3.75%▼ (in JPY terms)
Keyence|$455.26 (¥72,510)-1.28%▼ (in JPY terms)
Nintendo|$56.04 (¥8,926)+0.36%▲ (in JPY terms)
NTT|$1.07 (¥170)+0.77%▲ (in JPY terms)
Takeda|$43.52 (¥6,931)-0.09%▼ (in JPY terms)
Tokyo Electron|$54.35 (¥8,657)-1.56%▼ (in JPY terms)
Recruit|$114.24 (¥18,195)+5.02%▲ (in JPY terms)
ITOCHU|$14.65 (¥2,334)-2.59%▼ (in JPY terms)
Honda|$11.28 (¥1,797)-2.10%▼ (in JPY terms)
Shin-Etsu|$35.00 (¥5,574)-0.85%▼ (in JPY terms)
Tokio Marine|$3.67 (¥584)-2.23%▼ (in JPY terms)
Fast Retailing|$529.91 (¥84,400)+0.79%▲ (in JPY terms)
Toyota|$17.76 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$26.82 (¥4,271)-1.13%▼ (in JPY terms)
SoftBank|$20.60 (¥3,281)-3.95%▼ (in JPY terms)
MUFG|$20.64 (¥3,287)-3.75%▼ (in JPY terms)
Keyence|$455.26 (¥72,510)-1.28%▼ (in JPY terms)
Nintendo|$56.04 (¥8,926)+0.36%▲ (in JPY terms)
NTT|$1.07 (¥170)+0.77%▲ (in JPY terms)
Takeda|$43.52 (¥6,931)-0.09%▼ (in JPY terms)
Tokyo Electron|$54.35 (¥8,657)-1.56%▼ (in JPY terms)
Recruit|$114.24 (¥18,195)+5.02%▲ (in JPY terms)
ITOCHU|$14.65 (¥2,334)-2.59%▼ (in JPY terms)
Honda|$11.28 (¥1,797)-2.10%▼ (in JPY terms)
Shin-Etsu|$35.00 (¥5,574)-0.85%▼ (in JPY terms)
Tokio Marine|$3.67 (¥584)-2.23%▼ (in JPY terms)
Fast Retailing|$529.91 (¥84,400)+0.79%▲ (in JPY terms)

TERUMO CORPORATION (4543)

TSE 4543 · Precision Instruments

TERUMO CORPORATION

テルモ株式会社
$15.75 (¥2,508)
-8.0 (-0.32%)in JPY terms
Delayed quote · Yahoo Finance
🏢 Industry: Precision Instruments
🌐 ISIN: JP3546800008
📊 TSE: 4543
Company Overview

Terumo is one of Japan's leading medical device manufacturers, producing a comprehensive range of products including catheters, blood transfusion systems, surgical devices, and diabetes care equipment. The company serves healthcare providers across hospitals, clinics, and home care settings, with operations spanning Asia, the Americas, and Europe.

For international investors, Terumo offers meaningful exposure to the growing global medical device industry, underpinned by aging demographics and increasing healthcare utilization across both developed and emerging markets. The company's cardiovascular and interventional systems businesses are particularly well positioned to benefit from rising demand for minimally invasive cardiac procedures, while its established global sales network provides a stable platform for continued international expansion.

Recent Press Releases
2026-11-132026-11-12 TERUMO CORPORATION “Notice Regarding Revision of Consolidated Earnings Forecast for the Full Fiscal Year Ending March 2027 (PDF 86.32 KB).”2026-10-162026-10-15 TERUMO CORPORATION “Terumo has received the Good Design Award for the 31st consecutive year. In fiscal year 2026, the award will be given to four products: "CDI OneView Monitoring System," "TR Band Distal," "ChemoSafeFine," and "Terumo Electronic Thermometer P210."”2026-10-152026-10-14 TERUMO CORPORATION “Terumo and the University of Oxford in the UK have launched a six-year joint research project to advance organ perfusion technology, exploring its potential applications to new therapies beyond transplant medicine.”2026-10-102026-10-09 TERUMO CORPORATION “(Notice) Terumo BCT's statement regarding timely disclosure, published on October 8, 2026.”2026-10-092026-10-08 TERUMO CORPORATION “Notice Regarding Recording of Losses, etc., Due to Termination of Supply Contracts with Major Business Partners, and Revision of Consolidated Earnings Forecast for the Full Fiscal Year Ending March 2027 (PDF 178.4 KB).”2026-10-062026-10-05 TERUMO CORPORATION “Announcement of the release of "Terumo Report 2026".”2026-10-012026-09-30 TERUMO CORPORATION “Terumo has agreed to acquire Arsenal Medical, a US company specializing in cerebrovascular treatment technologies. By acquiring "NeoCast™," a liquid embolization material for chronic subdural hematoma currently under development, Terumo will expand its technology portfolio in the field of cerebrovascular treatment.”2026-08-262026-08-25 TERUMO CORPORATION “Terumo Europe has received the highest "Platinum" rating for the first time in a sustainability assessment conducted by EcoVadis, a French international evaluation organization.”2026-08-222026-08-21 TERUMO CORPORATION “Notice Regarding Changes in Subsidiary Companies (PDF 143.72 KB).”2026-08-082026-08-07 TERUMO CORPORATION “Notice Regarding Revision of Consolidated Earnings Forecast for the Full Fiscal Year Ending March 2027 (PDF 112.46 KB).”
Key Data
52W High
$16.88 (¥2,689)
52W Low
$11.93 (¥1,900)
TSE Code
4543
ISIN
JP3546800008